Skip to content
Biodatica
Start free

Investigator

Erik Sulman

NEW YORK UNIVERSITY SCHOOL OF MEDICINE · funded by NCI

Companies
1

Resolved onto their grants.

Grants
1

Federal awards on file.

Non-dilutive funding
$677k

Summed across those awards.

First award
Jul 28, 2023

On this record.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

  • Akeso

    OncologyPhase IListed · 9926.HK

    82momentum

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Exploiting cell fate transition to overcome radiation resistance in glioblastoma

    $677k

    Jul 28, 2023NCINEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11124133 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources